Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001164
UniProt IDP29033
Primary gene name(s)GJB2
Synonym gene name(s)unknown
Protein nameGap junction beta-2 protein
Protein functionOne gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
Subcellular locationCell membrane;
Multi-pass membrane protein. Cell junction, gap junction.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P29033
Gene Ontology
(Biological Process)
Complete annatation
cell-cell signaling [GO:0007267];
cellular response to oxidative stress [GO:0034599];
decidualization [GO:0046697];
gap junction assembly [GO:0016264];
male genitalia development [GO:0030539];
response to estradiol [GO:0032355];
response to human chorionic gonadotropin [GO:0044752];
response to progesterone [GO:0032570];
sensory perception of sound [GO:0007605];
transport [GO:0006810]
Gene Ontology
(Molecular Function)
Complete annatation
gap junction channel activity [GO:0005243]
Gene Ontology
(Cellular Component)
Complete annatation
connexon complex [GO:0005922];
endoplasmic reticulum-Golgi intermediate compartment [GO:0005793];
integral component of membrane [GO:0016021];
lateral plasma membrane [GO:0016328];
plasma membrane [GO:0005886]
Protein-protein interaction108972
Phylogenetic treeP29033
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.360668620657120.139080720360120.228670733857067
AZA vs. DISU-0.4746162739437840.6314264689696570.960057478314726
AZA vs. IL7-0.4239002579563030.6419298161884680.999311006273513
AZA vs. SAHA-0.5464434194351450.621902217928610.878633194652185
DISU vs. CD3-1.842367191643720.03094263338793780.0733738881433157
DISU vs. IL70.03775382988461330.9639547128719070.994449950565863
DISU vs. SAHA-0.06381980004678760.9508284857383920.989441867353937
DMSO vs. AZA-0.02173145485749790.9830324993073981
DMSO vs. CD3-1.373742096770180.1210279701543980.199144063187581
DMSO vs. DISU0.4572323804642540.6353461765669220.945993343259791
DMSO vs. IL7-0.3974264061494370.6509307675163960.925646761655472
DMSO vs. SAHA-0.5296993111529130.6267052490889030.8781147043588
HIV vs. Mock in Activation0.419499793437670.6582112377558830.999983755607037
HIV vs. Mock in Latencyunknownunknownunknown
IL7 vs. CD3-1.787505439221040.01127362410744560.0329316542968076
SAHA vs. CD3-1.918015341588380.06538889507413330.123733130181716
SAHA vs. IL7-0.1154495641689910.9062012314169060.964549654008503
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock 2.073 1.18E-12 6.43E-10
Infected vs. Bystander 2.352 7.91E-14 4.08E-11
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 1.01227 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
1XIR Model - A=1-226.
2ZW3 X-ray 3.5Å A/B/C/D/E/F=1-226.
3IZ1 EM - A/B/C=1-226.
3IZ2 EM - A/B/C=8-226.
5ER7 X-ray 3.2Å A/B=1-226.
5ERA X-ray 3.8Å A/B=1-226.
5KJ3 NMR - A=1-22.
5KJG NMR - A=1-22.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found
Menu